Steroidal and gonadotropin evaluation of a patient with a feminizing tumor of the adrenal gland. In vivo and in vitro studies.
D015065:17-Hydroxycorticosteroids / Q000096:biosynthesis / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D000315:Adrenalectomy; D002845:Chromatography; D003687:Dehydroepiandrosterone / Q000378:metabolism; D003900:Desoxycorticosterone / Q000096:biosynthesis; D003907:Dexamethasone; D004958:Estradiol / Q000096:biosynthesis; D004964:Estriol / Q000096:biosynthesis; D004967:Estrogens / Q000096:biosynthesis; D005262:Feminization / Q000378:metabolism; D005640:Follicle Stimulating Hormone / Q000097:blood; D006062:Gonadotropins / Q000652:urine*; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D066298:In Vitro Techniques; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008661:Metabolism, Inborn Errors; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009392:Nephrectomy; D011241:Prednisone / Q000627:therapeutic use; D011284:Pregnenolone / Q000378:metabolism; D011863:Radioimmunoassay; D012727:Sex Characteristics; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D006062:Gonadotropins; D014316:Tritium; D003900:Desoxycorticosterone; D003687:Dehydroepiandrosterone; D004958:Estradiol; D011284:Pregnenolone; D003907:Dexamethasone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D006899:Mixed Function Oxygenases; D004964:Estriol; D011241:Prednisone; D006854:Hydrocortisone